Cancer | BaroMedical Canada

Read more on Cancer Recovery here

Many cancer patients find conventional therapies either insufficient or difficult to tolerate due to debilitating side effects and long-term toxicity. While they may not wish to abandon standard treatments, many actively seek additional, science-backed strategies to complement their care. This growing demand has led researchers to explore safe, non-toxic, and integrative approaches to support cancer management.

One such promising method is the Press Pulse Protocol (PPP)—an innovative therapeutic model introduced by leading American researchers including Dr. Thomas N. Seyfried (Professor of Biology, Genetics, and Biochemistry at Boston College) and Dr. Dominic P. D’Agostino (Associate Professor at the University of South Florida). The PPP combines Hyperbaric Oxygen Therapy (HBOT) with a calorie-restricted ketogenic diet to target cancer’s metabolic vulnerabilities.

What Is the Press Pulse Protocol?

The Press Pulse Protocol is based on a two-pronged strategy:

Press: Sustained metabolic pressure is applied to cancer cells through interventions such as:

Calorie-restricted ketogenic diets (KD-R)
Ketone supplementation
Intermittent fasting
Stress-reduction techniques

Pulse: This involves periodic, targeted metabolic stressors like:

Glucose and glutamine restriction or inhibition
Hyperbaric Oxygen Therapy (HBOT)

The Science behind PPP and HBOT

The protocol is grounded in two well-established scientific observations:

Cancer cells depend heavily on glucose and glutamine for energy and growth—unlike healthy cells, which can adapt to ketones.
Most cancer cells thrive in low-oxygen environments, relying on fermentation (glycolysis) rather than oxygen-based energy production (oxidative phosphorylation).

Hyperbaric Oxygen Therapy introduces hyperoxia, a state where oxygen levels in the body's tissues and fluids are significantly increased. By saturating the interstitial fluid—where cancer cells reside—with oxygen, HBOT disrupts the anaerobic environment that cancer cells need to survive and propagate. This metabolic shift impairs cancer cell function and makes them more vulnerable to both conventional treatments and natural immune responses.

BaroMedical’s Expertise in HBOT

At BaroMedical Hyperbaric Oxygen Clinic, we bring over 25 years of experience delivering Health Canada-approved HBOT treatments in professionally operated, medically supervised hyperbaric chambers. Our team of medical hyperbaric specialists offers personalized pre-treatment assessments to design the safest and most effective protocols tailored to each individual’s needs and condition.

Otto Warburg, Nobel Prize Laureate

"All normal cells have an absolute requirement for oxygen, but cancer cells can live without oxygen - a rule without exception. Deprive a cell 35% of its oxygen for 48 hours and it may become cancerous."

Otto Warburg, German physiologist receiving Nobel Prize in Medicine in 1931 for his discovery that the root cause of cancer is oxygen deficiency, and proving that cancer cells are anaerobic (do not breathe oxygen) and cannot survive in the presence of high levels of oxygen.

Severe ulcerative breast cancer

Nancy P, Tofino BC

"I will always be grateful to BaroMedical for taking me on as a client.

I had an ulcerating breast tumour with severe MRSA infection and had almost bled to death on numerous occasions. Thanks to the hyperbaric treatments my breast tumour is shrinking, the bleeding has stopped and the infection is all but gone.

Not many clinics would have agreed to help me in the severe condition that I was in.

My sincerest thanks to everyone at BaroMedical for their help."

Press-Pulse Protocol Cancer Recovery

PressPulse Protocol Cancer Management

Otto Warburg, Nobel Prize Laureate